THE PROMISING ROLE OF SAFE INITIAL NON-CISPLATIN-CONTAINING COMBINATION CHEMOTHERAPY IN NASOPHARYNGEAL TUMORS

被引：9

作者：

HILL, BT

PRICE, LA

MACRAE, KD

机构：

[1] ROYAL MARSDEN HOSP,HEAD & NECK UNIT,LONDON,ENGLAND

[2] CHARING CROSS & WESTMINSTER HOSP,DEPT STAT,LONDON,ENGLAND

来源：

CANCER INVESTIGATION | 1987年 / 5卷 / 06期

关键词：

D O I：

10.3109/07357908709020310

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：517 / 522

页数：6

共 24 条

[1] TREATMENT OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CISPLATIN AND 5-FLUOROURACIL [J].

AMREIN, PC ;

WIETZMAN, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (12) :1632-1639

[2]

BEDWINEK JM, 1980, CANCER, V45, P2725, DOI 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO

[3]

2-1

[4]

DECKER DA, 1983, CANCER, V52, P602, DOI 10.1002/1097-0142(19830815)52:4<602::AID-CNCR2820520404>3.0.CO

[5]

2-6

[6]

ERRIN TJ, 1985, SEMIN ONCOL, V12, P71

[7] CARCINOMA OF THE NASOPHARYNX - A 25-YEAR STUDY [J].

HAGHBIN, M ;

KRAMER, S ;

PATCHEFSKY, AS ;

PRESTIPINO, AJ ;

DIENERWEST, MD .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (05) :384-392

[8] 24-HOUR COMBINATION CHEMOTHERAPY WITHOUT CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC HEAD AND NECK-CANCER [J].

HILL, BT ;

SHAW, HJ ;

DALLEY, VM ;

PRICE, LA .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (04) :335-340

[9] IMPORTANCE OF PRIMARY SITE IN ASSESSING CHEMOTHERAPY RESPONSE AND 7-YEAR SURVIVAL-DATA IN ADVANCED SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK TREATED WITH INITIAL COMBINATION CHEMOTHERAPY WITHOUT CISPLATIN [J].

HILL, BT ;

PRICE, LA ;

MACRAE, K .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1340-1347

[10]

HILL BT, 1984, ADJUVANT THERAPY CAN, V4, P97

← 1 2 3 →